Bettina Ryll is the founder of the Melanoma Patient Network Europe and was member of
the first EU Cancer Mission Board. A physician by training and with a PhD in Biomedical
Sciences from University College London, she became a patient advocate after losing her
husband to cancer.
Her work focuses on patient-centric innovation, covering the full spectrum from basic
research over successful translation and clinical trials to timely and equitable
implementation. Most recently and trigged by her work on the EU Cancer Mission Board,
her particular interest has been how to best leverage the potential of personalized medicine
for patients and society through novel forms of collaboration and the support of health
policy and governance.
Bettina Ryll currently works as strategist for Vision Zero Cancer, a mission-driven innovation
ecosystem in health financed by Sweden’s Innovation Agency Vinnova.

Building multi-stakeholder ecosystems to implement precision medicine in Europe- learnings from DRUP-Like Clinical Trials